Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1995-08-08
1998-02-03
Bernhardt, Emily
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
544354, A61K 31495, C07D40310
Patent
active
057144893
ABSTRACT:
2,3(1H,4H)-quinoxalinediones of the formula I ##STR1## where R.sup.1 is hydrogen, an aliphatic radical which has up to 12 carbons and can be substituted by one of the following: phenyl, cyclopentyl, cyclohexyl or --CO--R.sup.3, --CO--O--R.sup.3 or --CO--NH--R.sup.3, where R.sup.3 is hydrogen, C.sub.1 -C.sub.4 -alkyl, phenyl, benzyl or 1-phenylethyl,
REFERENCES:
patent: 3992378 (1976-11-01), St. Clair et al.
patent: 4889855 (1989-12-01), Jacobsen et al.
patent: 5283244 (1994-02-01), Sakamoto et al.
Lipton, TINS, vol. 16 pp. 527-532 (1993).
Sastry et al Indian Journal of Chemistry, vol. 28B, Oct. 1989, pp. 888-890.
Behl Berthold
Hofmann Hans Peter
Lubisch Wilfried
BASF - Aktiengesellschaft
Bernhardt Emily
LandOfFree
2,3(1H,4H)quinoxalinedione does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 2,3(1H,4H)quinoxalinedione, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2,3(1H,4H)quinoxalinedione will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-662549